Twist Bioscience Corp (OQ:TWST)
Business Focus: Biopharmaceuticals
Apr 18, 2024 08:00 am ET
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024, after market close on Thursday, May 2, 2024. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the co
Mar 28, 2024 08:00 am ET
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed to enable researchers to detect a more complete view of genetic var
Mar 05, 2024 08:00 am ET
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced European Union (EU) in vitro diagnostic regulations (IVDR) compliant
Feb 22, 2024 08:00 am ET
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:
Feb 07, 2024 08:00 am ET
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 122,400 restricted stock units (“RSUs”) to 36 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment inducement awards were granted under Twist’s Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with
Feb 06, 2024 08:05 am ET
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
Feb 06, 2024 08:00 am ET
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched the
Feb 05, 2024 08:00 am ET
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced technology early access of the Twist Flex Prep Ultra High-Throughput (UHT) Kit, which aims to enable unparalleled throughput at a fraction of the cost o
Feb 02, 2024 07:30 am ET
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2024 ended December 31, 2023.
Jan 24, 2024 08:00 am ET
Twist Bioscience Expands Express Genes Rapid Synthesis Service
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of
Jan 16, 2024 08:00 am ET
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 first quarter ended December 31, 2023, before the opening of the market on Friday, February 2, 2024. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be acc
Jan 08, 2024 08:00 am ET
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 50,000 restricted stock units (“RSUs”) and 70,000 shares subject to the Company’s executive compensation programs to Adam Laponis, Twist’s recently appointed chief financial officer, as an inducement material to his acceptance of employment with Twist. The employment inducement award was granted under Twist’
Jan 05, 2024 08:00 am ET
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer. Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track r
Dec 18, 2023 08:00 am ET
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8 at 5:15 p.m. Pacific Time in San Francisco, CA.
Nov 17, 2023 07:30 am ET
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the fourth quarter and full year fiscal 2023 ended September 30, 2023.
Nov 14, 2023 08:00 am ET
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of
Nov 13, 2023 08:00 am ET
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28 at 7:30 a.m. Eastern Time in Miami, FL.
Nov 08, 2023 08:00 am ET
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 130,400 restricted stock units (“RSUs”) to 15 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment inducement awards were granted under Twist’s Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635(c
Nov 02, 2023 04:05 pm ET
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended September 30, 2023, before the opening of the market on Friday, November 17, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial re
Oct 31, 2023 08:00 am ET
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of
Oct 05, 2023 09:00 pm ET
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Twist Bioscience Corp (NASDAQ: TWST) on behalf of long-term stockholders following a class action complaint that was filed...
Oct 05, 2023 08:00 am ET
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscie
Oct 03, 2023 08:00 am ET
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mark Buck as senior vice president, operations. Mr. Buck brings experience improving manufacturing efficiency and driving revenue and
Sep 27, 2023 08:00 am ET
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
Sep 05, 2023 08:00 am ET
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will participate in fireside chats at the following upcoming investor conferences:
Aug 31, 2023 03:00 am ET
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with
Aug 22, 2023 08:00 am ET
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today
Aug 07, 2023 08:00 am ET
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will participate in the Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine panel at the UBS MedTech, Tools and Genomics Summit 2023 on Tuesday, August 15 at 2:00 p.m. Pacific Time.
Aug 04, 2023 07:30 am ET
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2023 ended June 30, 2023.
Jul 20, 2023 08:00 am ET
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 third quarter ended June 30, 2023, before the opening of the market on Friday, August 4, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessibl
Jul 18, 2023 08:00 am ET
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
Jun 26, 2023 08:10 am ET
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced publication of preclinical data supporting the potential use of the highly potent and optimized GLP-1R antagonist antibody, TB-222-023, as a treatment f
Jun 20, 2023 08:00 am ET
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Chet Gandhi as chief information officer. Mr. Gandhi brings a wealth of experience in leading and executing software and
Jun 07, 2023 11:59 am ET
Lifshitz Law PLLC Announces Investigations of STEM, Inc. (NYSE: STEM), The Walt Disney Company (NYSE: DIS), Beyond Meat, Inc. (NASDAQ: BYND), and Twist Bioscience Corporation (NASDAQ: TWST)
STEM, Inc. (NYSE: STEM) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Offering Documents issued in connection with the Company’s...
May 31, 2023 08:00 am ET
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
May 24, 2023 08:00 am ET
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences:
May 23, 2023 08:00 am ET
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Robert Werner as chief accounting officer.
May 22, 2023 08:00 am ET
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a
May 10, 2023 08:00 am ET
Twist Bioscience to Present at ITF World 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at Imec Technology Forum (ITF) World 2023 in Antwerp, Belgium on Wed
May 05, 2023 07:30 am ET
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2023 ended March 31, 2023.
Apr 27, 2023 08:00 am ET
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
Apr 20, 2023 08:00 am ET
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suit
Apr 13, 2023 08:00 am ET
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of
Apr 13, 2023 07:59 am ET
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 second quarter ended March 31, 2023, before the opening of the market on Friday, May 5, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible
Mar 29, 2023 08:00 am ET
DNA Data Storage Alliance Announces Board Appointments
The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN),
Mar 17, 2023 05:00 pm ET
Lifshitz Law PLLC Announces Investigations of Twist Bioscience Corporation (NASDAQ: TWST), Sunlight Financial Holdings Inc. (NYSE: SUNL), Gaia, Inc. (NASDAQ: GAIA), and Daktronics, Inc. (NASDAQ: DAKT)
Twist Bioscience Corporation (NASDAQ: TWST) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company overstated the commercial...
Mar 16, 2023 09:00 pm ET
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Twist Bioscience Corp (NASDAQ: TWST) on behalf of long-term stockholders following a class action complaint that was filed against Twist on December 12, 2022 with a Class Period from December 13, 2019 to November 14, 2022. Our investigation concerns whether the board of directors of Twist have breached their fiduciary duties to the company.
Mar 09, 2023 08:00 am ET
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an
Feb 28, 2023 08:00 am ET
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences:
Feb 14, 2023 08:00 am ET
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today published on the successful discovery of alpaca-derived VHH antibodies using a disruptive, function-forward in vivo discovery workflow developed by Abveris
Feb 10, 2023 11:08 am ET
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the “Class Period”), of the important February 10, 2023 lead plaintiff deadline.
Feb 10, 2023 11:00 am ET
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Twist Bioscience Corporation ("Twist” or "the Company") (NASDAQ: TWST) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Twist securities between December 13, 2019, and November 14, 2022, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Feb 10, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Feb 09, 2023 08:45 pm ET
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / February 9, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Twist Bioscience Corporation ("Twist" or "the Company") (NASDAQ:TWST) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Feb 09, 2023 11:00 am ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ:
Feb 09, 2023 08:51 am ET
TWST FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys to Feb. 10th Deadline in Securities Class Actio
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Feb 09, 2023 08:49 am ET
Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Twist Bioscience Corporation (NASDAQ: TWST)
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist...
Feb 09, 2023 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Feb 09, 2023 12:32 am ET
Twist Bioscience Corporation: Please contact the Portnoy Law Firm to recover your losses; February 10, 2023 deadline
The Portnoy Law Firm advises Twist Bioscience Corporation (“TWST”) (NASDAQ: TWST) investors that a lawsuit filed on behalf of investors that purchased securities Twist Bioscience Corporation, Inc (NASDAQ: TWST) between December 13, 2019, and...
Feb 08, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iris, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Iris Energy Limited (NASDAQ: IREN), Twist Bioscience Corp (NASDAQ: TWST),...
Feb 08, 2023 07:16 pm ET
Twist Bioscience Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Twist Bioscience Corporation of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., Feb. 8, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of California and is assigned to the Honorable
Feb 08, 2023 12:00 pm ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
LOS ANGELES, Feb. 8, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Feb 08, 2023 11:30 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
Feb 08, 2023 10:45 am ET
TWST FINAL DEADLINE FRIDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the “Class Period”), of the important...
Feb 08, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Feb 07, 2023 08:05 pm ET
TWIST BIOSCIENCE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Twi
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company’s shares between December 13, 2019 and November 14, 2022, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Feb 07, 2023 08:00 am ET
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced technology early access of the Twist enhanced Whole Genome Sequencing (eWGS) solution focused on non-human genomics applications, at the Advances in Gen
Feb 07, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Feb 07, 2023 01:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Feb 06, 2023 11:50 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Feb 06, 2023 01:24 pm ET
Feb 06, 2023 12:15 pm ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 06, 2023 10:04 am ET
TWST & SUNL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 06, 2023 10:00 am ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
BENSALEM, Pa., Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Feb 04, 2023 07:04 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Feb 04, 2023 12:21 pm ET
Twist Bioscience Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Twist Bioscience Corporation Shareholders of Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist...
Feb 04, 2023 10:52 am ET
TWST 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys Before Feb. 10th Deadline in Securities Class A
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Feb 03, 2023 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
NEW ORLEANS, Feb. 3, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Feb 03, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight...
Feb 03, 2023 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation...
Feb 03, 2023 07:30 am ET
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2023 ended December 31, 2022.
Feb 03, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Feb 02, 2023 11:00 am ET
DEADLINE ALERT for FXLV, AFRM, SGLY, TWST: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 02, 2023 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Feb 01, 2023 09:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST
CEDARHURST, N.Y., Feb. 1, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). Shareholders have until February 10, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Feb 01, 2023 02:03 pm ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 01, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Feb 01, 2023 12:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 31, 2023 10:53 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they...
Jan 31, 2023 09:57 am ET
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Twist Bioscience Corporation
RADNOR, Pa., Jan. 31, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of California and is assigned to the Honorable
Jan 31, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Jan 31, 2023 01:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 30, 2023 06:47 pm ET
DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Twist Bioscience Corporation Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a
Jan 30, 2023 03:45 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Jan 30, 2023 02:46 pm ET
Jan 30, 2023 05:20 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 30, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Twist Investors of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) shareholders:
Jan 29, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight...
Jan 29, 2023 03:15 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Jan 29, 2023 11:50 am ET
CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors that the Firm Has Filed a Securities Fraud Class Action Lawsuit Filed against Twist Bioscience Corporation
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist...
Jan 27, 2023 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
NEW ORLEANS, Jan. 27, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Jan 27, 2023 03:18 pm ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
LOS ANGELES, Jan. 27, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Jan 27, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Jan 26, 2023 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation...
Jan 26, 2023 08:00 am ET
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the shipments of the first products from its second manufacturing site, the Factory of the Future, in Wilsonville, Oregon.
Jan 26, 2023 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Jan 25, 2023 08:45 pm ET
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Twist Bioscience Corporation ("Twist" or "the Company") (NASDAQ:TWST) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jan 25, 2023 12:00 pm ET
DEADLINE ALERT for FXLV, AFRM, SGLY, TWST: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 25, 2023 11:45 am ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 25, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Jan. 25, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Jan 24, 2023 11:28 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
Jan 24, 2023 10:00 am ET
COMP, TWST & SUNL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 24, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Jan 24, 2023 12:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 23, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight...
Jan 23, 2023 05:01 pm ET
Jan 23, 2023 01:00 pm ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 23, 2023 11:08 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Jan 23, 2023 10:00 am ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
LOS ANGELES, Jan. 23, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Jan 23, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Twist Investors of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Attention Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) shareholders:
Jan 21, 2023 06:14 pm ET
TWST Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 10, 2023 Deadline in Securities Fraud Class Action Lawsuit against Twist Bioscience Corporation
RADNOR, Pa., Jan. 21, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of California and is assigned to the Honorable
Jan 21, 2023 05:52 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Jan 20, 2023 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
NEW ORLEANS, Jan. 20, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Jan 20, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 20, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Jan 19, 2023 11:51 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
NEW YORK, Jan. 20, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 19, 2023 12:04 pm ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 19, 2023 12:00 pm ET
DEADLINE ALERT for FXLV, AFRM, SGLY, TWST: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 19, 2023 08:00 am ET
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be acc
Jan 19, 2023 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Jan 18, 2023 10:30 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company’s shares between December 13, 2019 and November 14, 2022, inclusive (the...
Jan 18, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight...
Jan 18, 2023 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation...
Jan 18, 2023 11:30 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 18, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Jan. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Jan 17, 2023 10:04 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they...
Jan 17, 2023 05:17 pm ET
Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 10, 2023 Deadline in Securities Fraud Class Action against Twist Bioscience Corporation Investors and Urges Investors with Substantial
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist...
Jan 17, 2023 04:00 pm ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 17, 2023 02:57 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Jan 17, 2023 10:00 am ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
BENSALEM, Pa., Jan. 17, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Jan 17, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Jan 16, 2023 10:00 am ET
COMP, TWST & SUNL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 16, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Twist Investors of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 16, 2023 /PRNewswire/ -- Attention Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) shareholders:
Jan 15, 2023 02:15 pm ET
TOP RANKED ROSEN LAW FIRM Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
NEW YORK, Jan. 15, 2023 /PRNewswire/ --
Jan 13, 2023 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
NEW ORLEANS, Jan. 13, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Jan 13, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twist, Sunlight, Gaia, and Tattooed Chef and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Twist Bioscience Corp (NASDAQ: TWST), Sunlight Financial Holdings, Inc. (NYSE:...
Jan 13, 2023 12:54 pm ET
Twist Bioscience Corporation (TWST) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Twist Bioscience Corporation
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Twist Bioscience Corporation (NASDAQ: TWST) common stock between December 13, 2019 and November 14,...
Jan 13, 2023 12:09 pm ET
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
RADNOR, Pa., Jan. 13, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of California and is assigned to the Honorable
Jan 13, 2023 11:35 am ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 13, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 13, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Jan 12, 2023 07:17 pm ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Jan 12, 2023 09:05 am ET
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
RADNOR, Pa., Jan. 12, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of California and is assigned to the Honorable
Jan 12, 2023 12:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 11, 2023 11:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 11, 2023 10:32 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST
CEDARHURST, N.Y., Jan. 11, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). Shareholders have until February 10, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Jan 11, 2023 07:01 pm ET
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a
Jan 11, 2023 03:21 pm ET
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – TWST
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the “Class Period”), of the...
Jan 11, 2023 11:00 am ET
DEADLINE ALERT for FXLV, AFRM, SGLY, TWST: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 11, 2023 10:44 am ET
Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist...
Jan 11, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Jan. 11, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Jan 10, 2023 02:31 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation...
Jan 10, 2023 08:00 am ET
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and
Jan 10, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Jan. 10, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Jan 10, 2023 04:45 am ET
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
NEW YORK, Jan. 10, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST) alleging that the Company violated federal securities laws.
Jan 10, 2023 01:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 09, 2023 03:43 pm ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
LOS ANGELES, Jan. 9, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Jan 09, 2023 03:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Jan 09, 2023 12:38 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Jan 09, 2023 07:00 am ET
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a research collaboration with
Jan 09, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Twist Investors of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Attention Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) shareholders:
Jan 08, 2023 09:05 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NewAge, Inc. (OTC: NBEVQ), Twist Bioscience Corp (NASDAQ: TWST), Sunlight...
Jan 06, 2023 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
NEW ORLEANS, Jan. 6, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Jan 06, 2023 05:04 pm ET
TWIST DEADLINE ALERT : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options
NEW YORK, Jan. 6, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) and reminds investors of the February 10, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jan 06, 2023 11:52 am ET
DEADLINE ALERT for TWST, IREN, SUNL, and DAKT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 06, 2023 10:00 am ET
COMP, TWST & SUNL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 06, 2023 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Jan. 6, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Jan 05, 2023 03:40 pm ET
Twist Bioscience Corporation (TWST) Equity Notice: Robbins LLP Urges Investors with Significant Losses to Contact the Firm
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Twist Bioscience Corporation (NASDAQ: TWST) common stock between December 13, 2019 and November 14,...
Jan 05, 2023 03:40 pm ET
Jan 05, 2023 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 5, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Jan 05, 2023 12:45 am ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 04, 2023 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company’s shares between December 13, 2019 and November 14, 2022, inclusive (the...
Jan 04, 2023 07:00 pm ET
Jan 04, 2023 12:00 pm ET
DEADLINE ALERT for FXLV, AFRM, SGLY, TWST: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 04, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)
NEW YORK, Jan. 4, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Twist Bioscience Corporation.
Jan 03, 2023 10:52 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they...
Jan 03, 2023 09:03 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Silvergate, Iris, NewAge, and Twist and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Silvergate Capital Corporation (NYSE: SI), Iris Energy Limited (NASDAQ: IREN),...
Jan 03, 2023 07:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
NEW YORK, Jan. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 03, 2023 07:12 pm ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – TWST
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the “Class Period”), of the important...
Jan 03, 2023 04:05 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action
Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 – Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit:...
Jan 03, 2023 12:30 pm ET
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 03, 2023 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Twist Bioscience Corporation...
Jan 03, 2023 08:00 am ET
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 41st Annual J.P. Morgan Health Care Conference on Monday, January 9th at 5:15 p.m. PST / 8:15 p.m. EST.
Jan 01, 2023 07:29 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Dec 30, 2022 09:50 pm ET
TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
NEW ORLEANS, Dec. 30, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
Dec 30, 2022 05:04 pm ET
TWIST DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options
NEW YORK, Dec. 30, 2022 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) and reminds investors of the February 10, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Dec 30, 2022 04:45 am ET
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
NEW YORK, Dec. 30, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Twist Bioscience Corporation (NASDAQ: TWST).
Dec 29, 2022 12:00 pm ET
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
LOS ANGELES, Dec. 29, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST).
Dec 29, 2022 04:45 am ET
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 29, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.
Dec 28, 2022 09:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST
CEDARHURST, N.Y., Dec. 28, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). Shareholders have until February 10, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Dec 28, 2022 09:20 pm ET
TWIST ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Twist Bioscience Corp (“Twist” or the “Company”) (NASDAQ: TWST) in the United States District...
Dec 28, 2022 04:55 pm ET
Twist Bioscience Corporation (TWST) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Twist Bioscience Corporation
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Twist Bioscience Corporation (NASDAQ: TWST) common stock between December 13, 2019 and November 14, 2022, for violations of the Securities Exchange Act of 1934. Twist is a biot
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.